title: Retinal angiomatous proliferation complicated by pigment epithelial tear following intravitreal bevacizumab treatment.
authors.forename: Farzin
authors.initials: F
authors.lastname: Forooghian
authors.forename: Catherine
authors.initials: C
authors.lastname: Cukras
authors.forename: Emily Y
authors.initials: EY
authors.lastname: Chew
mesh_terms: D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D004396:Coloring Agents; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007208:Indocyanine Green; D007267:Injections; D010857:Pigment Epithelium of Eye / Q000187:drug effects* / Q000473:pathology; D015861:Retinal Neovascularization / Q000175:diagnosis / Q000188:drug therapy*; D012167:Retinal Perforations / Q000139:chemically induced* / Q000175:diagnosis; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014822:Vitreous Body
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D004396:Coloring Agents; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D007208:Indocyanine Green